Chromoendoscopy in Inflammatory Bowel Disease

Status Recruiting

Clinical Trial Summary

Patients with longstanding ulcerative colitis (inflammatory bowel disease, IBD) have increased risk of developing colorectal cancer (CRC) when compared with that of the general population. Therefore patients with longstanding colitis undergo regular screening colonoscopy at varied time intervals depending on their individual risk. This is thought to detect early mucosal (interior bowel lining) abnormalities, known as dysplasia, which can progress to CRC. Until recently, IBD surveillance has relied upon colonoscopy with multiple (at least 33) random biopsies of the bowel lining to detect dysplasia, but now international guidelines recommended a technique called chromoendoscopy.

Chromoendoscopy involves applying a dye, called indigo-carmine, to the bowel lining whilst performing colonoscopy which highlights more subtle abnormalities, therefore increasing dysplasia detection rate.

There is no standard international concentration of the dye spray used during chromoendoscopy. Studies have used different concentrations of indigo-carmine dye ranging from 0.1 to 0.4%. We have recently shown that 0.2% dye improves detection rates compared to high definition white light. The recent international SCENIC guidelines suggest using 0.03% indigo-carmine via a foot pump. However there are no trials comparing the two methods and no previous trials have used the 0.03%. We therefore aim to perform a randomised control trial, comparing 0.03% indigo-carmine dye versus 0.2% in detecting dysplasia in patients undergoing surveillance colonoscopy in IBD. Any lesions seen will assessed using standard endoscopic appearance but also using optical biopsy forceps to further characterise the lesion, then manage the lesion as standard guidelines. We will also take two additional rectal biopsies, which will be snap frozen in liquid nitrogen and then studied using Raman Spectroscopy, Infra Red spectroscopy and electrochemical impedance to develop optical markers to identify patients at higher risk of dysplasia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03250780
Study type	Interventional
Source	The Leeds Teaching Hospitals NHS Trust
Contact	Venkataraman Subramanian, MBBS, MRCP, MD
Email	venkat.subramanian@nhs.net
Status	Recruiting
Phase	N/A
Start date	January 1, 2017
Completion date	January 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04101097` - Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
Completed	`NCT03247595` - Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy	N/A
Completed	`NCT04214301` - An Open-Label Preference Evaluation of BLI800	Phase 4
Withdrawn	`NCT05754255` - Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center	N/A
Recruiting	`NCT02484105` - Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction	Phase 4
Active, not recruiting	`NCT02264249` - Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation	N/A
Completed	`NCT01964417` - The Comparative Study Between Bowel Preparation Method	Phase 3
Terminated	`NCT01978509` - The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies	N/A
Recruiting	`NCT01685970` - Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy	Phase 3
Completed	`NCT01518790` - Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children	N/A
Recruiting	`NCT00748293` - Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet	N/A
Completed	`NCT00779649` - MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial	Phase 4
Completed	`NCT00671177` - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique	N/A
Completed	`NCT00380497` - Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children	Phase 4
Recruiting	`NCT00160823` - Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients	Phase 3
Completed	`NCT00390598` - PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy	Phase 2/Phase 3
Completed	`NCT00314418` - Patient Position and Impact on Colonoscopy Time	N/A
Completed	`NCT00209573` - A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy	Phase 3
Completed	`NCT00427089` - Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening	Phase 3
Completed	`NCT05823350` - The Effect of Abdominal Massage on Pain and Distention After Colonoscopy	N/A